Status:
RECRUITING
Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Conditions:
Hepatocellular Cancer
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
Prospective single arm, single center observational study to evaluate Quality of Life (Qol) after stereotactic body radiotherapy for patients with hepatocellular cancer. Patients will receive work-up,...
Detailed Description
Prospective single arm, single center observational study to evaluate Quality of Life (Qol) after stereotactic body radiotherapy (SBRT) for patients with hepatocellular cancer (HCC). Patients will rec...
Eligibility Criteria
Inclusion
- histologically or radiologically proven hepatocellular carcinoma
- 1-3 lesions suitable for stereotactic radiation therapy
- indication for SBRT according to multidisciplinary board evaluation
- age \>= 18 years
- written informed consent for study participation
- mental and verbal ability to complete standardized questionaires according to assessment by investigator (physician)
Exclusion
- age \< 18 years
- prior HCC specific systemic therapy
- concurrent oncological systemic treatment
- distant metastases
- inadequate ability tobe compliant with the protocol or to complete standardizes questionaires
- inability to receive contrast-enhanced planning CT
- missing ability to give informed consent
- legal custody
Key Trial Info
Start Date :
July 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 10 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03253536
Start Date
July 10 2017
End Date
July 10 2027
Last Update
August 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiation Oncology, University Hospital, LMU Munich
Munich, Bavaria, Germany, 81377